nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—Dapsone—malaria	0.153	0.319	CbGbCtD
Dasatinib—CYP1A1—Quinine—malaria	0.0339	0.0706	CbGbCtD
Dasatinib—CYP3A5—Artemether—malaria	0.0335	0.0699	CbGbCtD
Dasatinib—CYP1A1—Quinidine—malaria	0.0298	0.062	CbGbCtD
Dasatinib—CYP3A4—Clindamycin—malaria	0.0268	0.0558	CbGbCtD
Dasatinib—CYP1A2—Proguanil—malaria	0.0235	0.0489	CbGbCtD
Dasatinib—CYP3A5—Quinine—malaria	0.0203	0.0424	CbGbCtD
Dasatinib—CYP1A2—Pentoxifylline—malaria	0.0169	0.0351	CbGbCtD
Dasatinib—CYP3A5—Dapsone—malaria	0.0154	0.0321	CbGbCtD
Dasatinib—CYP3A4—Sulfadiazine—malaria	0.0154	0.0321	CbGbCtD
Dasatinib—CYP1A2—Quinine—malaria	0.0151	0.0315	CbGbCtD
Dasatinib—CYP1A2—Quinidine—malaria	0.0133	0.0277	CbGbCtD
Dasatinib—ABCB1—Quinine—malaria	0.0132	0.0276	CbGbCtD
Dasatinib—CYP3A4—Artemether—malaria	0.0131	0.0273	CbGbCtD
Dasatinib—CYP3A4—Proguanil—malaria	0.0123	0.0256	CbGbCtD
Dasatinib—CYP3A4—Doxycycline—malaria	0.0117	0.0243	CbGbCtD
Dasatinib—ABCB1—Quinidine—malaria	0.0116	0.0242	CbGbCtD
Dasatinib—CYP3A4—Quinine—malaria	0.00792	0.0165	CbGbCtD
Dasatinib—CYP3A4—Quinidine—malaria	0.00696	0.0145	CbGbCtD
Dasatinib—CYP3A4—Dapsone—malaria	0.00601	0.0125	CbGbCtD
Dasatinib—PTK6—blood—malaria	0.000895	0.00535	CbGeAlD
Dasatinib—EPHB1—liver—malaria	0.000889	0.00532	CbGeAlD
Dasatinib—STAT5B—digestive system—malaria	0.000888	0.00531	CbGeAlD
Dasatinib—SRMS—bone marrow—malaria	0.000884	0.00529	CbGeAlD
Dasatinib—TXK—bone marrow—malaria	0.000875	0.00523	CbGeAlD
Dasatinib—CSK—hematopoietic system—malaria	0.000864	0.00517	CbGeAlD
Dasatinib—HCK—hematopoietic system—malaria	0.000853	0.00511	CbGeAlD
Dasatinib—KIT—blood plasma—malaria	0.00085	0.00508	CbGeAlD
Dasatinib—STAT5B—blood—malaria	0.000846	0.00506	CbGeAlD
Dasatinib—RIPK2—saliva-secreting gland—malaria	0.000841	0.00503	CbGeAlD
Dasatinib—SIK1—saliva-secreting gland—malaria	0.000821	0.00491	CbGeAlD
Dasatinib—STAT5B—bone marrow—malaria	0.000819	0.0049	CbGeAlD
Dasatinib—ERBB3—saliva-secreting gland—malaria	0.000805	0.00481	CbGeAlD
Dasatinib—RIPK2—hematopoietic system—malaria	0.000802	0.0048	CbGeAlD
Dasatinib—SIK2—liver—malaria	0.000785	0.0047	CbGeAlD
Dasatinib—SIK1—hematopoietic system—malaria	0.000783	0.00469	CbGeAlD
Dasatinib—ERBB3—hematopoietic system—malaria	0.000768	0.00459	CbGeAlD
Dasatinib—FRK—liver—malaria	0.000765	0.00458	CbGeAlD
Dasatinib—MAP3K2—hematopoietic system—malaria	0.000761	0.00455	CbGeAlD
Dasatinib—ZAK—digestive system—malaria	0.000742	0.00444	CbGeAlD
Dasatinib—EPHA5—digestive system—malaria	0.000726	0.00435	CbGeAlD
Dasatinib—MAPK14—hematopoietic system—malaria	0.000715	0.00428	CbGeAlD
Dasatinib—FGR—hematopoietic system—malaria	0.000712	0.00426	CbGeAlD
Dasatinib—EPHB4—saliva-secreting gland—malaria	0.00071	0.00425	CbGeAlD
Dasatinib—CSK—kidney—malaria	0.000709	0.00424	CbGeAlD
Dasatinib—ZAK—blood—malaria	0.000707	0.00423	CbGeAlD
Dasatinib—EPHB1—brain—malaria	0.000705	0.00422	CbGeAlD
Dasatinib—EPHA2—saliva-secreting gland—malaria	0.000697	0.00417	CbGeAlD
Dasatinib—LYN—blood—malaria	0.000688	0.00412	CbGeAlD
Dasatinib—MAP4K5—saliva-secreting gland—malaria	0.00068	0.00407	CbGeAlD
Dasatinib—MAP3K3—saliva-secreting gland—malaria	0.00068	0.00407	CbGeAlD
Dasatinib—EPHB4—hematopoietic system—malaria	0.000678	0.00406	CbGeAlD
Dasatinib—BTK—blood—malaria	0.000675	0.00404	CbGeAlD
Dasatinib—JAK2—hematopoietic system—malaria	0.000673	0.00403	CbGeAlD
Dasatinib—EPHA2—hematopoietic system—malaria	0.000665	0.00398	CbGeAlD
Dasatinib—FYN—hematopoietic system—malaria	0.000664	0.00397	CbGeAlD
Dasatinib—STAT5B—liver—malaria	0.000662	0.00396	CbGeAlD
Dasatinib—BTK—bone marrow—malaria	0.000653	0.00391	CbGeAlD
Dasatinib—EPHB6—saliva-secreting gland—malaria	0.00065	0.00389	CbGeAlD
Dasatinib—MAP3K3—hematopoietic system—malaria	0.000649	0.00388	CbGeAlD
Dasatinib—MAP4K5—hematopoietic system—malaria	0.000649	0.00388	CbGeAlD
Dasatinib—EPHB3—digestive system—malaria	0.000646	0.00386	CbGeAlD
Dasatinib—SIK1—kidney—malaria	0.000642	0.00384	CbGeAlD
Dasatinib—ERBB3—kidney—malaria	0.000629	0.00377	CbGeAlD
Dasatinib—YES1—saliva-secreting gland—malaria	0.000628	0.00376	CbGeAlD
Dasatinib—TESK1—blood—malaria	0.000625	0.00374	CbGeAlD
Dasatinib—SIK2—brain—malaria	0.000623	0.00373	CbGeAlD
Dasatinib—STK36—blood—malaria	0.000615	0.00368	CbGeAlD
Dasatinib—PKMYT1—brain—malaria	0.000607	0.00363	CbGeAlD
Dasatinib—CSK—digestive system—malaria	0.000601	0.0036	CbGeAlD
Dasatinib—YES1—hematopoietic system—malaria	0.000599	0.00359	CbGeAlD
Dasatinib—SIK3—liver—malaria	0.000595	0.00356	CbGeAlD
Dasatinib—LIMK2—blood—malaria	0.000595	0.00356	CbGeAlD
Dasatinib—HCK—digestive system—malaria	0.000593	0.00355	CbGeAlD
Dasatinib—PDGFRA—hematopoietic system—malaria	0.000588	0.00352	CbGeAlD
Dasatinib—MAPK14—kidney—malaria	0.000586	0.00351	CbGeAlD
Dasatinib—EPHB2—brain—malaria	0.000579	0.00346	CbGeAlD
Dasatinib—SRC—hematopoietic system—malaria	0.000576	0.00345	CbGeAlD
Dasatinib—CSK—blood—malaria	0.000573	0.00343	CbGeAlD
Dasatinib—SRMS—brain—malaria	0.000567	0.00339	CbGeAlD
Dasatinib—HCK—blood—malaria	0.000565	0.00338	CbGeAlD
Dasatinib—ABL2—blood—malaria	0.000562	0.00336	CbGeAlD
Dasatinib—RIPK2—digestive system—malaria	0.000558	0.00334	CbGeAlD
Dasatinib—EPHB4—kidney—malaria	0.000556	0.00332	CbGeAlD
Dasatinib—MAP2K5—saliva-secreting gland—malaria	0.000556	0.00332	CbGeAlD
Dasatinib—EPHA8—brain—malaria	0.000555	0.00332	CbGeAlD
Dasatinib—CSK—bone marrow—malaria	0.000554	0.00332	CbGeAlD
Dasatinib—ZAK—liver—malaria	0.000553	0.00331	CbGeAlD
Dasatinib—JAK2—kidney—malaria	0.000552	0.0033	CbGeAlD
Dasatinib—HCK—bone marrow—malaria	0.000547	0.00327	CbGeAlD
Dasatinib—FYN—kidney—malaria	0.000544	0.00326	CbGeAlD
Dasatinib—LYN—liver—malaria	0.000538	0.00322	CbGeAlD
Dasatinib—ERBB3—digestive system—malaria	0.000534	0.0032	CbGeAlD
Dasatinib—RIPK2—blood—malaria	0.000532	0.00318	CbGeAlD
Dasatinib—BTK—liver—malaria	0.000528	0.00316	CbGeAlD
Dasatinib—STAT5B—brain—malaria	0.000525	0.00314	CbGeAlD
Dasatinib—TNK2—liver—malaria	0.00052	0.00311	CbGeAlD
Dasatinib—SIK1—blood—malaria	0.000519	0.00311	CbGeAlD
Dasatinib—CSF1R—hematopoietic system—malaria	0.000517	0.0031	CbGeAlD
Dasatinib—RIPK2—bone marrow—malaria	0.000514	0.00308	CbGeAlD
Dasatinib—EPHA4—blood—malaria	0.000514	0.00307	CbGeAlD
Dasatinib—MAP3K2—blood—malaria	0.000504	0.00302	CbGeAlD
Dasatinib—SIK1—bone marrow—malaria	0.000502	0.00301	CbGeAlD
Dasatinib—MAPK14—digestive system—malaria	0.000497	0.00298	CbGeAlD
Dasatinib—FGR—digestive system—malaria	0.000495	0.00296	CbGeAlD
Dasatinib—KIT—saliva-secreting gland—malaria	0.000492	0.00295	CbGeAlD
Dasatinib—YES1—kidney—malaria	0.000491	0.00294	CbGeAlD
Dasatinib—TESK1—liver—malaria	0.000489	0.00293	CbGeAlD
Dasatinib—MAP3K2—bone marrow—malaria	0.000488	0.00292	CbGeAlD
Dasatinib—EPHA3—brain—malaria	0.000485	0.0029	CbGeAlD
Dasatinib—STK36—liver—malaria	0.000481	0.00288	CbGeAlD
Dasatinib—PDGFRB—saliva-secreting gland—malaria	0.000481	0.00288	CbGeAlD
Dasatinib—MAPK14—blood—malaria	0.000474	0.00283	CbGeAlD
Dasatinib—SRC—kidney—malaria	0.000472	0.00283	CbGeAlD
Dasatinib—SIK3—brain—malaria	0.000472	0.00282	CbGeAlD
Dasatinib—FGR—blood—malaria	0.000472	0.00282	CbGeAlD
Dasatinib—LCK—blood—malaria	0.000472	0.00282	CbGeAlD
Dasatinib—EPHB4—digestive system—malaria	0.000471	0.00282	CbGeAlD
Dasatinib—KIT—hematopoietic system—malaria	0.00047	0.00281	CbGeAlD
Dasatinib—JAK2—digestive system—malaria	0.000468	0.0028	CbGeAlD
Dasatinib—LIMK2—liver—malaria	0.000465	0.00278	CbGeAlD
Dasatinib—EPHA2—digestive system—malaria	0.000463	0.00277	CbGeAlD
Dasatinib—FYN—digestive system—malaria	0.000462	0.00276	CbGeAlD
Dasatinib—PDGFRB—hematopoietic system—malaria	0.000459	0.00275	CbGeAlD
Dasatinib—MAPK14—bone marrow—malaria	0.000458	0.00274	CbGeAlD
Dasatinib—FGR—bone marrow—malaria	0.000457	0.00273	CbGeAlD
Dasatinib—LCK—bone marrow—malaria	0.000457	0.00273	CbGeAlD
Dasatinib—STK35—liver—malaria	0.000451	0.0027	CbGeAlD
Dasatinib—EPHB4—blood—malaria	0.000449	0.00269	CbGeAlD
Dasatinib—CYP1A2—blood plasma—malaria	0.000449	0.00269	CbGeAlD
Dasatinib—CSK—liver—malaria	0.000448	0.00268	CbGeAlD
Dasatinib—JAK2—blood—malaria	0.000446	0.00267	CbGeAlD
Dasatinib—HCK—liver—malaria	0.000442	0.00265	CbGeAlD
Dasatinib—EPHA2—blood—malaria	0.000441	0.00264	CbGeAlD
Dasatinib—FYN—blood—malaria	0.00044	0.00263	CbGeAlD
Dasatinib—ABL2—liver—malaria	0.000439	0.00263	CbGeAlD
Dasatinib—ZAK—brain—malaria	0.000439	0.00263	CbGeAlD
Dasatinib—EPHB4—bone marrow—malaria	0.000435	0.0026	CbGeAlD
Dasatinib—CYP3A5—blood plasma—malaria	0.000433	0.00259	CbGeAlD
Dasatinib—JAK2—bone marrow—malaria	0.000432	0.00258	CbGeAlD
Dasatinib—MAP4K5—blood—malaria	0.00043	0.00257	CbGeAlD
Dasatinib—MAP3K3—blood—malaria	0.00043	0.00257	CbGeAlD
Dasatinib—EPHA5—brain—malaria	0.000429	0.00257	CbGeAlD
Dasatinib—ABL1—saliva-secreting gland—malaria	0.000429	0.00256	CbGeAlD
Dasatinib—LYN—brain—malaria	0.000427	0.00256	CbGeAlD
Dasatinib—FYN—bone marrow—malaria	0.000426	0.00255	CbGeAlD
Dasatinib—BMPR1B—brain—malaria	0.000421	0.00252	CbGeAlD
Dasatinib—MAP3K19—brain—malaria	0.000421	0.00252	CbGeAlD
Dasatinib—BTK—brain—malaria	0.000419	0.0025	CbGeAlD
Dasatinib—YES1—digestive system—malaria	0.000417	0.00249	CbGeAlD
Dasatinib—MAP3K3—bone marrow—malaria	0.000416	0.00249	CbGeAlD
Dasatinib—MAP4K5—bone marrow—malaria	0.000416	0.00249	CbGeAlD
Dasatinib—RIPK2—liver—malaria	0.000416	0.00249	CbGeAlD
Dasatinib—TNK2—brain—malaria	0.000413	0.00247	CbGeAlD
Dasatinib—EPHB6—blood—malaria	0.000411	0.00246	CbGeAlD
Dasatinib—ABL1—hematopoietic system—malaria	0.000409	0.00245	CbGeAlD
Dasatinib—PDGFRA—digestive system—malaria	0.000409	0.00245	CbGeAlD
Dasatinib—SIK1—liver—malaria	0.000406	0.00243	CbGeAlD
Dasatinib—SRC—digestive system—malaria	0.000401	0.0024	CbGeAlD
Dasatinib—ERBB3—liver—malaria	0.000398	0.00238	CbGeAlD
Dasatinib—YES1—blood—malaria	0.000397	0.00238	CbGeAlD
Dasatinib—MAP3K2—liver—malaria	0.000394	0.00236	CbGeAlD
Dasatinib—PDGFRA—blood—malaria	0.000389	0.00233	CbGeAlD
Dasatinib—TESK1—brain—malaria	0.000388	0.00232	CbGeAlD
Dasatinib—KIT—kidney—malaria	0.000385	0.0023	CbGeAlD
Dasatinib—YES1—bone marrow—malaria	0.000384	0.0023	CbGeAlD
Dasatinib—SRC—blood—malaria	0.000382	0.00228	CbGeAlD
Dasatinib—STK36—brain—malaria	0.000382	0.00228	CbGeAlD
Dasatinib—EPHB3—brain—malaria	0.000382	0.00228	CbGeAlD
Dasatinib—PDGFRB—kidney—malaria	0.000376	0.00225	CbGeAlD
Dasatinib—MAPK14—liver—malaria	0.000371	0.00222	CbGeAlD
Dasatinib—LIMK2—brain—malaria	0.000369	0.00221	CbGeAlD
Dasatinib—FGR—liver—malaria	0.000369	0.00221	CbGeAlD
Dasatinib—LCK—liver—malaria	0.000369	0.00221	CbGeAlD
Dasatinib—CSF1R—digestive system—malaria	0.00036	0.00215	CbGeAlD
Dasatinib—STK35—brain—malaria	0.000358	0.00214	CbGeAlD
Dasatinib—FMO3—liver—malaria	0.000356	0.00213	CbGeAlD
Dasatinib—CSK—brain—malaria	0.000355	0.00213	CbGeAlD
Dasatinib—MAP2K5—blood—malaria	0.000351	0.0021	CbGeAlD
Dasatinib—EPHB4—liver—malaria	0.000351	0.0021	CbGeAlD
Dasatinib—HCK—brain—malaria	0.000351	0.0021	CbGeAlD
Dasatinib—JAK2—liver—malaria	0.000349	0.00209	CbGeAlD
Dasatinib—ABL2—brain—malaria	0.000349	0.00209	CbGeAlD
Dasatinib—CYP1B1—hematopoietic system—malaria	0.000346	0.00207	CbGeAlD
Dasatinib—EPHA2—liver—malaria	0.000345	0.00206	CbGeAlD
Dasatinib—FYN—liver—malaria	0.000344	0.00206	CbGeAlD
Dasatinib—CSF1R—blood—malaria	0.000343	0.00205	CbGeAlD
Dasatinib—MAP4K5—liver—malaria	0.000336	0.00201	CbGeAlD
Dasatinib—MAP3K3—liver—malaria	0.000336	0.00201	CbGeAlD
Dasatinib—ABL1—kidney—malaria	0.000335	0.00201	CbGeAlD
Dasatinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000334	0.00183	CcSEcCtD
Dasatinib—Erythema—Clindamycin—malaria	0.000332	0.00182	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000332	0.00182	CcSEcCtD
Dasatinib—CSF1R—bone marrow—malaria	0.000332	0.00198	CbGeAlD
Dasatinib—Urethral disorder—Quinidine barbiturate—malaria	0.000331	0.00182	CcSEcCtD
Dasatinib—RIPK2—brain—malaria	0.00033	0.00197	CbGeAlD
Dasatinib—Insomnia—Sulfadiazine—malaria	0.000329	0.00181	CcSEcCtD
Dasatinib—Mental disorder—Quinidine—malaria	0.000328	0.0018	CcSEcCtD
Dasatinib—Mental disorder—Quinine—malaria	0.000328	0.0018	CcSEcCtD
Dasatinib—KIT—digestive system—malaria	0.000327	0.00196	CbGeAlD
Dasatinib—Erythema—Quinidine—malaria	0.000326	0.00179	CcSEcCtD
Dasatinib—Malnutrition—Quinine—malaria	0.000326	0.00179	CcSEcCtD
Dasatinib—Malnutrition—Quinidine—malaria	0.000326	0.00179	CcSEcCtD
Dasatinib—Erythema—Quinine—malaria	0.000326	0.00179	CcSEcCtD
Dasatinib—Nausea—Proguanil—malaria	0.000326	0.00179	CcSEcCtD
Dasatinib—Visual impairment—Quinidine barbiturate—malaria	0.000326	0.00178	CcSEcCtD
Dasatinib—Dysgeusia—Clindamycin—malaria	0.000325	0.00178	CcSEcCtD
Dasatinib—CYP3A4—blood plasma—malaria	0.000325	0.00194	CbGeAlD
Dasatinib—Vision blurred—Dapsone—malaria	0.000324	0.00177	CcSEcCtD
Dasatinib—SIK1—brain—malaria	0.000322	0.00193	CbGeAlD
Dasatinib—Erythema multiforme—Quinidine barbiturate—malaria	0.00032	0.00175	CcSEcCtD
Dasatinib—Muscle spasms—Clindamycin—malaria	0.00032	0.00175	CcSEcCtD
Dasatinib—PDGFRB—digestive system—malaria	0.000319	0.00191	CbGeAlD
Dasatinib—EPHA4—brain—malaria	0.000319	0.00191	CbGeAlD
Dasatinib—Decreased appetite—Sulfadiazine—malaria	0.000317	0.00174	CcSEcCtD
Dasatinib—Eye disorder—Quinidine barbiturate—malaria	0.000316	0.00173	CcSEcCtD
Dasatinib—ERBB3—brain—malaria	0.000316	0.00189	CbGeAlD
Dasatinib—Tinnitus—Quinidine barbiturate—malaria	0.000315	0.00173	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000314	0.00172	CcSEcCtD
Dasatinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000314	0.00172	CcSEcCtD
Dasatinib—Flushing—Quinidine barbiturate—malaria	0.000314	0.00172	CcSEcCtD
Dasatinib—Flushing—Pentoxifylline—malaria	0.000313	0.00172	CcSEcCtD
Dasatinib—MAP3K2—brain—malaria	0.000313	0.00187	CbGeAlD
Dasatinib—KIT—blood—malaria	0.000311	0.00186	CbGeAlD
Dasatinib—YES1—liver—malaria	0.00031	0.00186	CbGeAlD
Dasatinib—Vertigo—Dapsone—malaria	0.000309	0.00169	CcSEcCtD
Dasatinib—Vision blurred—Quinidine—malaria	0.000307	0.00168	CcSEcCtD
Dasatinib—Vision blurred—Quinine—malaria	0.000307	0.00168	CcSEcCtD
Dasatinib—Anaemia—Clindamycin—malaria	0.000307	0.00168	CcSEcCtD
Dasatinib—Tremor—Quinidine—malaria	0.000305	0.00167	CcSEcCtD
Dasatinib—Tremor—Quinine—malaria	0.000305	0.00167	CcSEcCtD
Dasatinib—Immune system disorder—Quinidine barbiturate—malaria	0.000305	0.00167	CcSEcCtD
Dasatinib—Immune system disorder—Pentoxifylline—malaria	0.000305	0.00167	CcSEcCtD
Dasatinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000305	0.00167	CcSEcCtD
Dasatinib—PDGFRA—liver—malaria	0.000305	0.00182	CbGeAlD
Dasatinib—PDGFRB—blood—malaria	0.000304	0.00182	CbGeAlD
Dasatinib—Chills—Quinidine barbiturate—malaria	0.000303	0.00166	CcSEcCtD
Dasatinib—Arrhythmia—Pentoxifylline—malaria	0.000301	0.00165	CcSEcCtD
Dasatinib—KIT—bone marrow—malaria	0.000301	0.0018	CbGeAlD
Dasatinib—Cough—Dapsone—malaria	0.0003	0.00164	CcSEcCtD
Dasatinib—SRC—liver—malaria	0.000299	0.00179	CbGeAlD
Dasatinib—Vertigo—Clindamycin—malaria	0.000299	0.00164	CcSEcCtD
Dasatinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000298	0.00163	CcSEcCtD
Dasatinib—Mental disorder—Quinidine barbiturate—malaria	0.000296	0.00162	CcSEcCtD
Dasatinib—Malnutrition—Quinidine barbiturate—malaria	0.000294	0.00161	CcSEcCtD
Dasatinib—Erythema—Quinidine barbiturate—malaria	0.000294	0.00161	CcSEcCtD
Dasatinib—PDGFRB—bone marrow—malaria	0.000294	0.00176	CbGeAlD
Dasatinib—MAPK14—brain—malaria	0.000294	0.00176	CbGeAlD
Dasatinib—Erythema—Pentoxifylline—malaria	0.000294	0.00161	CcSEcCtD
Dasatinib—Vertigo—Quinine—malaria	0.000293	0.00161	CcSEcCtD
Dasatinib—Vertigo—Quinidine—malaria	0.000293	0.00161	CcSEcCtD
Dasatinib—FGR—brain—malaria	0.000293	0.00175	CbGeAlD
Dasatinib—Syncope—Quinidine—malaria	0.000292	0.0016	CcSEcCtD
Dasatinib—Syncope—Quinine—malaria	0.000292	0.0016	CcSEcCtD
Dasatinib—Urticaria—Sulfadiazine—malaria	0.000289	0.00159	CcSEcCtD
Dasatinib—Palpitations—Quinidine—malaria	0.000288	0.00158	CcSEcCtD
Dasatinib—Palpitations—Quinine—malaria	0.000288	0.00158	CcSEcCtD
Dasatinib—Abdominal pain—Sulfadiazine—malaria	0.000288	0.00158	CcSEcCtD
Dasatinib—Body temperature increased—Sulfadiazine—malaria	0.000288	0.00158	CcSEcCtD
Dasatinib—Dysgeusia—Pentoxifylline—malaria	0.000288	0.00158	CcSEcCtD
Dasatinib—Hypertension—Clindamycin—malaria	0.000287	0.00157	CcSEcCtD
Dasatinib—Loss of consciousness—Quinidine—malaria	0.000287	0.00157	CcSEcCtD
Dasatinib—Loss of consciousness—Quinine—malaria	0.000287	0.00157	CcSEcCtD
Dasatinib—ABL1—digestive system—malaria	0.000284	0.0017	CbGeAlD
Dasatinib—CYP1B1—kidney—malaria	0.000284	0.0017	CbGeAlD
Dasatinib—FMO3—brain—malaria	0.000283	0.00169	CbGeAlD
Dasatinib—Convulsion—Quinine—malaria	0.000283	0.00155	CcSEcCtD
Dasatinib—Convulsion—Quinidine—malaria	0.000283	0.00155	CcSEcCtD
Dasatinib—Muscle spasms—Pentoxifylline—malaria	0.000282	0.00155	CcSEcCtD
Dasatinib—Discomfort—Clindamycin—malaria	0.00028	0.00153	CcSEcCtD
Dasatinib—EPHB4—brain—malaria	0.000279	0.00167	CbGeAlD
Dasatinib—Chest pain—Quinine—malaria	0.000278	0.00152	CcSEcCtD
Dasatinib—Chest pain—Quinidine—malaria	0.000278	0.00152	CcSEcCtD
Dasatinib—Myalgia—Quinidine—malaria	0.000278	0.00152	CcSEcCtD
Dasatinib—Myalgia—Quinine—malaria	0.000278	0.00152	CcSEcCtD
Dasatinib—Vision blurred—Quinidine barbiturate—malaria	0.000277	0.00152	CcSEcCtD
Dasatinib—Vision blurred—Pentoxifylline—malaria	0.000277	0.00152	CcSEcCtD
Dasatinib—JAK2—brain—malaria	0.000277	0.00166	CbGeAlD
Dasatinib—Tremor—Quinidine barbiturate—malaria	0.000276	0.00151	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000276	0.00151	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000276	0.00151	CcSEcCtD
Dasatinib—Tremor—Pentoxifylline—malaria	0.000275	0.00151	CcSEcCtD
Dasatinib—MAP2K5—liver—malaria	0.000275	0.00164	CbGeAlD
Dasatinib—Tachycardia—Dapsone—malaria	0.000274	0.0015	CcSEcCtD
Dasatinib—EPHA2—brain—malaria	0.000273	0.00164	CbGeAlD
Dasatinib—FYN—brain—malaria	0.000273	0.00163	CbGeAlD
Dasatinib—Ill-defined disorder—Pentoxifylline—malaria	0.000273	0.00149	CcSEcCtD
Dasatinib—Anaemia—Pentoxifylline—malaria	0.000271	0.00149	CcSEcCtD
Dasatinib—ABL1—blood—malaria	0.000271	0.00162	CbGeAlD
Dasatinib—ABCG2—saliva-secreting gland—malaria	0.00027	0.00162	CbGeAlD
Dasatinib—Hypersensitivity—Sulfadiazine—malaria	0.000268	0.00147	CcSEcCtD
Dasatinib—Confusional state—Quinidine—malaria	0.000268	0.00147	CcSEcCtD
Dasatinib—Confusional state—Quinine—malaria	0.000268	0.00147	CcSEcCtD
Dasatinib—CSF1R—liver—malaria	0.000268	0.0016	CbGeAlD
Dasatinib—MAP4K5—brain—malaria	0.000267	0.0016	CbGeAlD
Dasatinib—MAP3K3—brain—malaria	0.000267	0.0016	CbGeAlD
Dasatinib—Oedema—Quinidine—malaria	0.000266	0.00146	CcSEcCtD
Dasatinib—Oedema—Quinine—malaria	0.000266	0.00146	CcSEcCtD
Dasatinib—Thrombocytopenia—Clindamycin—malaria	0.000266	0.00146	CcSEcCtD
Dasatinib—Malaise—Pentoxifylline—malaria	0.000265	0.00145	CcSEcCtD
Dasatinib—Vertigo—Quinidine barbiturate—malaria	0.000264	0.00145	CcSEcCtD
Dasatinib—Syncope—Quinidine barbiturate—malaria	0.000264	0.00145	CcSEcCtD
Dasatinib—ABL1—bone marrow—malaria	0.000262	0.00157	CbGeAlD
Dasatinib—Shock—Quinidine—malaria	0.000262	0.00143	CcSEcCtD
Dasatinib—Shock—Quinine—malaria	0.000262	0.00143	CcSEcCtD
Dasatinib—Nervous system disorder—Quinine—malaria	0.000261	0.00143	CcSEcCtD
Dasatinib—Nervous system disorder—Quinidine—malaria	0.000261	0.00143	CcSEcCtD
Dasatinib—Thrombocytopenia—Quinidine—malaria	0.000261	0.00143	CcSEcCtD
Dasatinib—Thrombocytopenia—Quinine—malaria	0.000261	0.00143	CcSEcCtD
Dasatinib—Palpitations—Quinidine barbiturate—malaria	0.00026	0.00142	CcSEcCtD
Dasatinib—Tachycardia—Quinine—malaria	0.00026	0.00142	CcSEcCtD
Dasatinib—Tachycardia—Quinidine—malaria	0.00026	0.00142	CcSEcCtD
Dasatinib—Palpitations—Pentoxifylline—malaria	0.00026	0.00142	CcSEcCtD
Dasatinib—Loss of consciousness—Quinidine barbiturate—malaria	0.000259	0.00142	CcSEcCtD
Dasatinib—Skin disorder—Quinidine—malaria	0.000258	0.00142	CcSEcCtD
Dasatinib—Skin disorder—Quinine—malaria	0.000258	0.00142	CcSEcCtD
Dasatinib—Pruritus—Sulfadiazine—malaria	0.000258	0.00141	CcSEcCtD
Dasatinib—Hyperhidrosis—Quinidine—malaria	0.000257	0.00141	CcSEcCtD
Dasatinib—Hyperhidrosis—Quinine—malaria	0.000257	0.00141	CcSEcCtD
Dasatinib—Convulsion—Quinidine barbiturate—malaria	0.000255	0.0014	CcSEcCtD
Dasatinib—EPHB6—brain—malaria	0.000255	0.00153	CbGeAlD
Dasatinib—Convulsion—Pentoxifylline—malaria	0.000254	0.00139	CcSEcCtD
Dasatinib—Anorexia—Quinidine—malaria	0.000254	0.00139	CcSEcCtD
Dasatinib—Anorexia—Quinine—malaria	0.000254	0.00139	CcSEcCtD
Dasatinib—Insomnia—Dapsone—malaria	0.000254	0.00139	CcSEcCtD
Dasatinib—Hypertension—Pentoxifylline—malaria	0.000254	0.00139	CcSEcCtD
Dasatinib—Hypotension—Clindamycin—malaria	0.000253	0.00139	CcSEcCtD
Dasatinib—Myalgia—Quinidine barbiturate—malaria	0.000251	0.00137	CcSEcCtD
Dasatinib—Chest pain—Quinidine barbiturate—malaria	0.000251	0.00137	CcSEcCtD
Dasatinib—Arthralgia—Quinidine barbiturate—malaria	0.000251	0.00137	CcSEcCtD
Dasatinib—Myalgia—Pentoxifylline—malaria	0.00025	0.00137	CcSEcCtD
Dasatinib—Chest pain—Pentoxifylline—malaria	0.00025	0.00137	CcSEcCtD
Dasatinib—Anxiety—Quinidine barbiturate—malaria	0.00025	0.00137	CcSEcCtD
Dasatinib—Diarrhoea—Sulfadiazine—malaria	0.000249	0.00137	CcSEcCtD
Dasatinib—Anxiety—Pentoxifylline—malaria	0.000249	0.00137	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000249	0.00136	CcSEcCtD
Dasatinib—Hypotension—Quinidine—malaria	0.000249	0.00136	CcSEcCtD
Dasatinib—Hypotension—Quinine—malaria	0.000249	0.00136	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000248	0.00136	CcSEcCtD
Dasatinib—CYP1A2—hematopoietic system—malaria	0.000248	0.00149	CbGeAlD
Dasatinib—Discomfort—Pentoxifylline—malaria	0.000247	0.00135	CcSEcCtD
Dasatinib—YES1—brain—malaria	0.000246	0.00147	CbGeAlD
Dasatinib—CYP1A1—hematopoietic system—malaria	0.000245	0.00147	CbGeAlD
Dasatinib—KIT—liver—malaria	0.000243	0.00146	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Quinidine—malaria	0.000242	0.00133	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Quinine—malaria	0.000242	0.00133	CcSEcCtD
Dasatinib—Confusional state—Quinidine barbiturate—malaria	0.000242	0.00133	CcSEcCtD
Dasatinib—Dyspnoea—Clindamycin—malaria	0.000242	0.00133	CcSEcCtD
Dasatinib—Confusional state—Pentoxifylline—malaria	0.000242	0.00132	CcSEcCtD
Dasatinib—PDGFRA—brain—malaria	0.000242	0.00145	CbGeAlD
Dasatinib—CYP1B1—digestive system—malaria	0.000241	0.00144	CbGeAlD
Dasatinib—Oedema—Quinidine barbiturate—malaria	0.00024	0.00132	CcSEcCtD
Dasatinib—Oedema—Pentoxifylline—malaria	0.00024	0.00131	CcSEcCtD
Dasatinib—CYP3A5—hematopoietic system—malaria	0.000239	0.00143	CbGeAlD
Dasatinib—Dyspepsia—Clindamycin—malaria	0.000239	0.00131	CcSEcCtD
Dasatinib—Infection—Pentoxifylline—malaria	0.000238	0.0013	CcSEcCtD
Dasatinib—PDGFRB—liver—malaria	0.000238	0.00142	CbGeAlD
Dasatinib—Dyspnoea—Quinidine—malaria	0.000237	0.0013	CcSEcCtD
Dasatinib—Dyspnoea—Quinine—malaria	0.000237	0.0013	CcSEcCtD
Dasatinib—SRC—brain—malaria	0.000237	0.00142	CbGeAlD
Dasatinib—Shock—Quinidine barbiturate—malaria	0.000236	0.00129	CcSEcCtD
Dasatinib—Shock—Pentoxifylline—malaria	0.000236	0.00129	CcSEcCtD
Dasatinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000236	0.00129	CcSEcCtD
Dasatinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000235	0.00129	CcSEcCtD
Dasatinib—Thrombocytopenia—Pentoxifylline—malaria	0.000235	0.00129	CcSEcCtD
Dasatinib—Tachycardia—Quinidine barbiturate—malaria	0.000234	0.00128	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Clindamycin—malaria	0.000234	0.00128	CcSEcCtD
Dasatinib—Tachycardia—Pentoxifylline—malaria	0.000234	0.00128	CcSEcCtD
Dasatinib—Fatigue—Clindamycin—malaria	0.000234	0.00128	CcSEcCtD
Dasatinib—Skin disorder—Quinidine barbiturate—malaria	0.000233	0.00128	CcSEcCtD
Dasatinib—Skin disorder—Pentoxifylline—malaria	0.000233	0.00128	CcSEcCtD
Dasatinib—Hyperhidrosis—Quinidine barbiturate—malaria	0.000232	0.00127	CcSEcCtD
Dasatinib—Constipation—Clindamycin—malaria	0.000232	0.00127	CcSEcCtD
Dasatinib—Pain—Clindamycin—malaria	0.000232	0.00127	CcSEcCtD
Dasatinib—Hyperhidrosis—Pentoxifylline—malaria	0.000232	0.00127	CcSEcCtD
Dasatinib—Vomiting—Sulfadiazine—malaria	0.000232	0.00127	CcSEcCtD
Dasatinib—Decreased appetite—Quinine—malaria	0.000231	0.00127	CcSEcCtD
Dasatinib—Decreased appetite—Quinidine—malaria	0.000231	0.00127	CcSEcCtD
Dasatinib—ABCB1—blood plasma—malaria	0.00023	0.00138	CbGeAlD
Dasatinib—Gastrointestinal disorder—Quinidine—malaria	0.00023	0.00126	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Quinine—malaria	0.00023	0.00126	CcSEcCtD
Dasatinib—Rash—Sulfadiazine—malaria	0.00023	0.00126	CcSEcCtD
Dasatinib—CYP1B1—blood—malaria	0.00023	0.00137	CbGeAlD
Dasatinib—Dermatitis—Sulfadiazine—malaria	0.000229	0.00126	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dapsone—malaria	0.000229	0.00126	CcSEcCtD
Dasatinib—Anorexia—Quinidine barbiturate—malaria	0.000229	0.00125	CcSEcCtD
Dasatinib—Anorexia—Pentoxifylline—malaria	0.000229	0.00125	CcSEcCtD
Dasatinib—Headache—Sulfadiazine—malaria	0.000228	0.00125	CcSEcCtD
Dasatinib—Hypotension—Quinidine barbiturate—malaria	0.000224	0.00123	CcSEcCtD
Dasatinib—Hypotension—Pentoxifylline—malaria	0.000224	0.00123	CcSEcCtD
Dasatinib—Gastrointestinal pain—Clindamycin—malaria	0.000222	0.00122	CcSEcCtD
Dasatinib—Body temperature increased—Dapsone—malaria	0.000222	0.00121	CcSEcCtD
Dasatinib—Abdominal pain—Dapsone—malaria	0.000222	0.00121	CcSEcCtD
Dasatinib—Feeling abnormal—Quinidine—malaria	0.000219	0.0012	CcSEcCtD
Dasatinib—Feeling abnormal—Quinine—malaria	0.000219	0.0012	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000219	0.0012	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000218	0.0012	CcSEcCtD
Dasatinib—MAP2K5—brain—malaria	0.000218	0.0013	CbGeAlD
Dasatinib—Gastrointestinal pain—Quinidine—malaria	0.000218	0.00119	CcSEcCtD
Dasatinib—Gastrointestinal pain—Quinine—malaria	0.000218	0.00119	CcSEcCtD
Dasatinib—Insomnia—Pentoxifylline—malaria	0.000217	0.00119	CcSEcCtD
Dasatinib—Nausea—Sulfadiazine—malaria	0.000216	0.00119	CcSEcCtD
Dasatinib—Urticaria—Clindamycin—malaria	0.000215	0.00118	CcSEcCtD
Dasatinib—Abdominal pain—Clindamycin—malaria	0.000214	0.00117	CcSEcCtD
Dasatinib—Body temperature increased—Clindamycin—malaria	0.000214	0.00117	CcSEcCtD
Dasatinib—Dyspnoea—Quinidine barbiturate—malaria	0.000214	0.00117	CcSEcCtD
Dasatinib—Dyspnoea—Pentoxifylline—malaria	0.000214	0.00117	CcSEcCtD
Dasatinib—Somnolence—Quinidine barbiturate—malaria	0.000214	0.00117	CcSEcCtD
Dasatinib—Somnolence—Pentoxifylline—malaria	0.000213	0.00117	CcSEcCtD
Dasatinib—CSF1R—brain—malaria	0.000213	0.00127	CbGeAlD
Dasatinib—ABL1—liver—malaria	0.000212	0.00127	CbGeAlD
Dasatinib—Urticaria—Quinidine—malaria	0.000211	0.00116	CcSEcCtD
Dasatinib—Urticaria—Quinine—malaria	0.000211	0.00116	CcSEcCtD
Dasatinib—Dyspepsia—Pentoxifylline—malaria	0.000211	0.00116	CcSEcCtD
Dasatinib—Abdominal pain—Quinine—malaria	0.00021	0.00115	CcSEcCtD
Dasatinib—Body temperature increased—Quinine—malaria	0.00021	0.00115	CcSEcCtD
Dasatinib—Abdominal pain—Quinidine—malaria	0.00021	0.00115	CcSEcCtD
Dasatinib—Body temperature increased—Quinidine—malaria	0.00021	0.00115	CcSEcCtD
Dasatinib—Decreased appetite—Quinidine barbiturate—malaria	0.000209	0.00114	CcSEcCtD
Dasatinib—Decreased appetite—Pentoxifylline—malaria	0.000208	0.00114	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000207	0.00114	CcSEcCtD
Dasatinib—Pain—Quinidine barbiturate—malaria	0.000205	0.00113	CcSEcCtD
Dasatinib—Constipation—Quinidine barbiturate—malaria	0.000205	0.00113	CcSEcCtD
Dasatinib—Constipation—Pentoxifylline—malaria	0.000205	0.00112	CcSEcCtD
Dasatinib—CYP1A1—kidney—malaria	0.000201	0.0012	CbGeAlD
Dasatinib—Hypersensitivity—Clindamycin—malaria	0.0002	0.0011	CcSEcCtD
Dasatinib—Feeling abnormal—Quinidine barbiturate—malaria	0.000198	0.00108	CcSEcCtD
Dasatinib—Feeling abnormal—Pentoxifylline—malaria	0.000198	0.00108	CcSEcCtD
Dasatinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000196	0.00108	CcSEcCtD
Dasatinib—CYP3A5—kidney—malaria	0.000196	0.00117	CbGeAlD
Dasatinib—Hypersensitivity—Quinine—malaria	0.000196	0.00107	CcSEcCtD
Dasatinib—Hypersensitivity—Quinidine—malaria	0.000196	0.00107	CcSEcCtD
Dasatinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000196	0.00107	CcSEcCtD
Dasatinib—Asthenia—Clindamycin—malaria	0.000195	0.00107	CcSEcCtD
Dasatinib—KIT—brain—malaria	0.000193	0.00116	CbGeAlD
Dasatinib—Pruritus—Clindamycin—malaria	0.000192	0.00105	CcSEcCtD
Dasatinib—Asthenia—Quinidine—malaria	0.000191	0.00105	CcSEcCtD
Dasatinib—Asthenia—Quinine—malaria	0.000191	0.00105	CcSEcCtD
Dasatinib—Urticaria—Quinidine barbiturate—malaria	0.000191	0.00105	CcSEcCtD
Dasatinib—Urticaria—Pentoxifylline—malaria	0.00019	0.00104	CcSEcCtD
Dasatinib—Body temperature increased—Quinidine barbiturate—malaria	0.00019	0.00104	CcSEcCtD
Dasatinib—Abdominal pain—Quinidine barbiturate—malaria	0.00019	0.00104	CcSEcCtD
Dasatinib—Body temperature increased—Pentoxifylline—malaria	0.00019	0.00104	CcSEcCtD
Dasatinib—Abdominal pain—Pentoxifylline—malaria	0.00019	0.00104	CcSEcCtD
Dasatinib—PDGFRB—brain—malaria	0.000189	0.00113	CbGeAlD
Dasatinib—Pruritus—Quinine—malaria	0.000188	0.00103	CcSEcCtD
Dasatinib—Pruritus—Quinidine—malaria	0.000188	0.00103	CcSEcCtD
Dasatinib—Diarrhoea—Clindamycin—malaria	0.000186	0.00102	CcSEcCtD
Dasatinib—Diarrhoea—Quinidine—malaria	0.000182	0.000998	CcSEcCtD
Dasatinib—Diarrhoea—Quinine—malaria	0.000182	0.000998	CcSEcCtD
Dasatinib—CYP3A4—hematopoietic system—malaria	0.00018	0.00108	CbGeAlD
Dasatinib—CYP1B1—liver—malaria	0.000179	0.00107	CbGeAlD
Dasatinib—Dizziness—Clindamycin—malaria	0.000179	0.000983	CcSEcCtD
Dasatinib—Vomiting—Dapsone—malaria	0.000178	0.000977	CcSEcCtD
Dasatinib—Hypersensitivity—Quinidine barbiturate—malaria	0.000177	0.000969	CcSEcCtD
Dasatinib—Hypersensitivity—Pentoxifylline—malaria	0.000177	0.000968	CcSEcCtD
Dasatinib—Dizziness—Quinidine—malaria	0.000176	0.000964	CcSEcCtD
Dasatinib—Dizziness—Quinine—malaria	0.000176	0.000964	CcSEcCtD
Dasatinib—Headache—Dapsone—malaria	0.000176	0.000963	CcSEcCtD
Dasatinib—CYP1A2—digestive system—malaria	0.000173	0.00103	CbGeAlD
Dasatinib—Vomiting—Clindamycin—malaria	0.000172	0.000945	CcSEcCtD
Dasatinib—Asthenia—Quinidine barbiturate—malaria	0.000172	0.000944	CcSEcCtD
Dasatinib—Asthenia—Pentoxifylline—malaria	0.000172	0.000942	CcSEcCtD
Dasatinib—Rash—Clindamycin—malaria	0.000171	0.000937	CcSEcCtD
Dasatinib—ABCG2—blood—malaria	0.000171	0.00102	CbGeAlD
Dasatinib—Dermatitis—Clindamycin—malaria	0.000171	0.000936	CcSEcCtD
Dasatinib—CYP1A1—digestive system—malaria	0.00017	0.00102	CbGeAlD
Dasatinib—Headache—Clindamycin—malaria	0.00017	0.000931	CcSEcCtD
Dasatinib—Pruritus—Quinidine barbiturate—malaria	0.00017	0.000931	CcSEcCtD
Dasatinib—Pruritus—Pentoxifylline—malaria	0.00017	0.000929	CcSEcCtD
Dasatinib—Vomiting—Quinine—malaria	0.000169	0.000927	CcSEcCtD
Dasatinib—Vomiting—Quinidine—malaria	0.000169	0.000927	CcSEcCtD
Dasatinib—ABL1—brain—malaria	0.000168	0.00101	CbGeAlD
Dasatinib—Rash—Quinidine—malaria	0.000168	0.000919	CcSEcCtD
Dasatinib—Rash—Quinine—malaria	0.000168	0.000919	CcSEcCtD
Dasatinib—Dermatitis—Quinidine—malaria	0.000168	0.000918	CcSEcCtD
Dasatinib—Dermatitis—Quinine—malaria	0.000168	0.000918	CcSEcCtD
Dasatinib—Headache—Quinine—malaria	0.000167	0.000913	CcSEcCtD
Dasatinib—Headache—Quinidine—malaria	0.000167	0.000913	CcSEcCtD
Dasatinib—Nausea—Dapsone—malaria	0.000167	0.000913	CcSEcCtD
Dasatinib—CYP3A5—digestive system—malaria	0.000167	0.000996	CbGeAlD
Dasatinib—ABCG2—bone marrow—malaria	0.000165	0.000989	CbGeAlD
Dasatinib—CYP1A2—blood—malaria	0.000164	0.000984	CbGeAlD
Dasatinib—Diarrhoea—Quinidine barbiturate—malaria	0.000164	0.0009	CcSEcCtD
Dasatinib—Diarrhoea—Pentoxifylline—malaria	0.000164	0.000899	CcSEcCtD
Dasatinib—CYP1A1—blood—malaria	0.000162	0.000971	CbGeAlD
Dasatinib—Nausea—Clindamycin—malaria	0.000161	0.000883	CcSEcCtD
Dasatinib—Dizziness—Quinidine barbiturate—malaria	0.000159	0.00087	CcSEcCtD
Dasatinib—CYP3A5—blood—malaria	0.000159	0.000949	CbGeAlD
Dasatinib—Dizziness—Pentoxifylline—malaria	0.000159	0.000869	CcSEcCtD
Dasatinib—Nausea—Quinidine—malaria	0.000158	0.000866	CcSEcCtD
Dasatinib—Nausea—Quinine—malaria	0.000158	0.000866	CcSEcCtD
Dasatinib—Vomiting—Quinidine barbiturate—malaria	0.000153	0.000837	CcSEcCtD
Dasatinib—Vomiting—Pentoxifylline—malaria	0.000152	0.000835	CcSEcCtD
Dasatinib—Rash—Quinidine barbiturate—malaria	0.000151	0.00083	CcSEcCtD
Dasatinib—Dermatitis—Quinidine barbiturate—malaria	0.000151	0.000829	CcSEcCtD
Dasatinib—Rash—Pentoxifylline—malaria	0.000151	0.000828	CcSEcCtD
Dasatinib—Dermatitis—Pentoxifylline—malaria	0.000151	0.000827	CcSEcCtD
Dasatinib—Headache—Quinidine barbiturate—malaria	0.00015	0.000824	CcSEcCtD
Dasatinib—Headache—Pentoxifylline—malaria	0.00015	0.000823	CcSEcCtD
Dasatinib—CYP3A4—kidney—malaria	0.000147	0.000881	CbGeAlD
Dasatinib—Nausea—Quinidine barbiturate—malaria	0.000143	0.000782	CcSEcCtD
Dasatinib—CYP1B1—brain—malaria	0.000142	0.000852	CbGeAlD
Dasatinib—Nausea—Pentoxifylline—malaria	0.000142	0.00078	CcSEcCtD
Dasatinib—ABCG2—liver—malaria	0.000134	0.0008	CbGeAlD
Dasatinib—CYP1A2—liver—malaria	0.000129	0.00077	CbGeAlD
Dasatinib—ABCB1—hematopoietic system—malaria	0.000127	0.000761	CbGeAlD
Dasatinib—CYP1A1—liver—malaria	0.000127	0.000759	CbGeAlD
Dasatinib—CYP3A4—digestive system—malaria	0.000125	0.000748	CbGeAlD
Dasatinib—CYP3A5—liver—malaria	0.000124	0.000742	CbGeAlD
Dasatinib—CYP3A4—blood—malaria	0.000119	0.000712	CbGeAlD
Dasatinib—ABCG2—brain—malaria	0.000106	0.000635	CbGeAlD
Dasatinib—ABCB1—kidney—malaria	0.000104	0.000624	CbGeAlD
Dasatinib—CYP1A1—brain—malaria	0.000101	0.000602	CbGeAlD
Dasatinib—CYP3A4—liver—malaria	9.31e-05	0.000557	CbGeAlD
Dasatinib—ABCB1—digestive system—malaria	8.85e-05	0.000529	CbGeAlD
Dasatinib—ABCB1—blood—malaria	8.43e-05	0.000504	CbGeAlD
Dasatinib—ABCB1—bone marrow—malaria	8.15e-05	0.000488	CbGeAlD
Dasatinib—ABCB1—liver—malaria	6.59e-05	0.000394	CbGeAlD
Dasatinib—ABCB1—brain—malaria	5.23e-05	0.000313	CbGeAlD
Dasatinib—ERBB3—Immune System—CD4—malaria	1.04e-05	6.12e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by NGF—IL6—malaria	1.04e-05	6.1e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CRP—malaria	1.03e-05	6.05e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—NOS2—malaria	1.02e-05	5.98e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CRP—malaria	1.01e-05	5.93e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CRP—malaria	1.01e-05	5.9e-05	CbGpPWpGaD
Dasatinib—LYN—Axon guidance—IL6—malaria	1.01e-05	5.9e-05	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—IL6—malaria	1e-05	5.87e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC4A1—malaria	1e-05	5.87e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CRP—malaria	9.95e-06	5.83e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—KDR—malaria	9.93e-06	5.82e-05	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—IL6—malaria	9.91e-06	5.81e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—TLR4—malaria	9.9e-06	5.8e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL18—malaria	9.89e-06	5.8e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD40LG—malaria	9.86e-06	5.78e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—IL2—malaria	9.82e-06	5.76e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD8A—malaria	9.75e-06	5.71e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL2—malaria	9.74e-06	5.71e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—TLR4—malaria	9.69e-06	5.68e-05	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—IL6—malaria	9.69e-06	5.68e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS2—malaria	9.65e-06	5.66e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—TLR4—malaria	9.65e-06	5.66e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL1B—malaria	9.64e-06	5.65e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—CD4—malaria	9.63e-06	5.65e-05	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—IL6—malaria	9.63e-06	5.64e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—CD4—malaria	9.61e-06	5.63e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL2—malaria	9.6e-06	5.63e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CRP—malaria	9.58e-06	5.62e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—KDR—malaria	9.58e-06	5.61e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—TLR4—malaria	9.54e-06	5.59e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PKLR—malaria	9.51e-06	5.57e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—ICAM1—malaria	9.49e-06	5.56e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IFNG—malaria	9.48e-06	5.56e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CRP—malaria	9.46e-06	5.55e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL2—malaria	9.43e-06	5.53e-05	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—IL6—malaria	9.42e-06	5.52e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DECR1—malaria	9.41e-06	5.52e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-B—malaria	9.38e-06	5.5e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—ICAM1—malaria	9.29e-06	5.45e-05	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	9.27e-06	5.43e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—ICAM1—malaria	9.25e-06	5.42e-05	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD4—malaria	9.23e-06	5.41e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD36—malaria	9.19e-06	5.39e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—TLR4—malaria	9.19e-06	5.39e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD4—malaria	9.16e-06	5.37e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—ICAM1—malaria	9.15e-06	5.36e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—IL6—malaria	9.11e-06	5.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DHODH—malaria	9.09e-06	5.33e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—TLR4—malaria	9.07e-06	5.32e-05	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—malaria	8.9e-06	5.22e-05	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—malaria	8.86e-06	5.19e-05	CbGpPWpGaD
Dasatinib—CSK—Immune System—IL6—malaria	8.85e-06	5.19e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—ICAM1—malaria	8.81e-06	5.16e-05	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—malaria	8.76e-06	5.13e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL18—malaria	8.76e-06	5.13e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD40LG—malaria	8.73e-06	5.11e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—ICAM1—malaria	8.7e-06	5.1e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—IL2—malaria	8.7e-06	5.1e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS2—malaria	8.69e-06	5.1e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD8A—malaria	8.63e-06	5.06e-05	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—IL6—malaria	8.57e-06	5.03e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—HPGDS—malaria	8.56e-06	5.02e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HBB—malaria	8.51e-06	4.99e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CD4—malaria	8.51e-06	4.99e-05	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—IL6—malaria	8.5e-06	4.98e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—G6PD—malaria	8.47e-06	4.97e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IFNG—malaria	8.47e-06	4.96e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL1B—malaria	8.46e-06	4.96e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—malaria	8.43e-06	4.94e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL2—malaria	8.43e-06	4.94e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—KDR—malaria	8.41e-06	4.93e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS2—malaria	8.38e-06	4.91e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—malaria	8.33e-06	4.88e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-B—malaria	8.3e-06	4.87e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CRP—malaria	8.29e-06	4.86e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD4—malaria	8.18e-06	4.79e-05	CbGpPWpGaD
Dasatinib—CSK—Disease—IL6—malaria	8.17e-06	4.79e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD4—malaria	8.17e-06	4.79e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	8.17e-06	4.79e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD36—malaria	8.14e-06	4.77e-05	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—IL6—malaria	8.12e-06	4.76e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—HPGDS—malaria	8.09e-06	4.74e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—IL6—malaria	8.07e-06	4.73e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IFNG—malaria	8.02e-06	4.7e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS2—malaria	7.97e-06	4.67e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—TLR4—malaria	7.95e-06	4.66e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—DHFR—malaria	7.94e-06	4.66e-05	CbGpPWpGaD
Dasatinib—STAT5B—Disease—IL6—malaria	7.92e-06	4.64e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SCARB1—malaria	7.86e-06	4.61e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD4—malaria	7.74e-06	4.54e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC4A1—malaria	7.73e-06	4.53e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—ICAM1—malaria	7.62e-06	4.46e-05	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—IL6—malaria	7.61e-06	4.46e-05	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—IL6—malaria	7.6e-06	4.45e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PKLR—malaria	7.59e-06	4.45e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CD36—malaria	7.57e-06	4.44e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL1B—malaria	7.55e-06	4.43e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—CD4—malaria	7.55e-06	4.43e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL2—malaria	7.53e-06	4.41e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—KDR—malaria	7.51e-06	4.4e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—DHFR—malaria	7.5e-06	4.4e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SCARB1—malaria	7.43e-06	4.35e-05	CbGpPWpGaD
Dasatinib—BTK—Immune System—IL6—malaria	7.41e-06	4.34e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CRP—malaria	7.34e-06	4.3e-05	CbGpPWpGaD
Dasatinib—SRC—Axon guidance—IL6—malaria	7.3e-06	4.28e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DECR1—malaria	7.27e-06	4.26e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IFNG—malaria	7.22e-06	4.23e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—IL6—malaria	7.19e-06	4.21e-05	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—IL6—malaria	7.18e-06	4.21e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL1B—malaria	7.15e-06	4.19e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CD4—malaria	7.15e-06	4.19e-05	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—IL6—malaria	7.15e-06	4.19e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL2—malaria	7.12e-06	4.18e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—KDR—malaria	7.11e-06	4.16e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—IL2—malaria	7.09e-06	4.15e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IFNG—malaria	7.07e-06	4.14e-05	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—IL6—malaria	7.07e-06	4.14e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL2—malaria	7.04e-06	4.13e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IFNG—malaria	7.04e-06	4.13e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—TLR4—malaria	7.03e-06	4.12e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS2—malaria	6.98e-06	4.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD4—malaria	6.98e-06	4.09e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IFNG—malaria	6.96e-06	4.08e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CD36—malaria	6.89e-06	4.04e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD4—malaria	6.83e-06	4e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—IL6—malaria	6.81e-06	3.99e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD4—malaria	6.8e-06	3.98e-05	CbGpPWpGaD
Dasatinib—HCK—Immune System—IL6—malaria	6.8e-06	3.98e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—G6PD—malaria	6.76e-06	3.96e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—ICAM1—malaria	6.74e-06	3.95e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD4—malaria	6.72e-06	3.94e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—IL6—malaria	6.72e-06	3.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IFNG—malaria	6.7e-06	3.93e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	6.67e-06	3.91e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IFNG—malaria	6.62e-06	3.88e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HBB—malaria	6.57e-06	3.85e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—IL6—malaria	6.48e-06	3.8e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD4—malaria	6.47e-06	3.79e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—HPGDS—malaria	6.46e-06	3.79e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—malaria	6.46e-06	3.78e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL1B—malaria	6.44e-06	3.78e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CD4—malaria	6.44e-06	3.78e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL2—malaria	6.44e-06	3.77e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL2—malaria	6.44e-06	3.77e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL2—malaria	6.42e-06	3.76e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—KDR—malaria	6.4e-06	3.75e-05	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—IL6—malaria	6.4e-06	3.75e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD4—malaria	6.39e-06	3.75e-05	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—IL6—malaria	6.34e-06	3.72e-05	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—IL6—malaria	6.31e-06	3.7e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1B—malaria	6.31e-06	3.7e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL2—malaria	6.28e-06	3.68e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1B—malaria	6.28e-06	3.68e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—IL6—malaria	6.27e-06	3.68e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—KDR—malaria	6.27e-06	3.67e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL2—malaria	6.25e-06	3.67e-05	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—IL6—malaria	6.24e-06	3.66e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1B—malaria	6.21e-06	3.64e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD4—malaria	6.21e-06	3.64e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL2—malaria	6.21e-06	3.64e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL2—malaria	6.19e-06	3.63e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS2—malaria	6.18e-06	3.62e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—KDR—malaria	6.17e-06	3.62e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL6—malaria	6.16e-06	3.61e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL6—malaria	6.14e-06	3.6e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—IL6—malaria	6.01e-06	3.52e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—DHFR—malaria	5.99e-06	3.51e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—malaria	5.98e-06	3.5e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—malaria	5.96e-06	3.49e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—KDR—malaria	5.94e-06	3.48e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—IL6—malaria	5.93e-06	3.48e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SCARB1—malaria	5.93e-06	3.48e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—malaria	5.9e-06	3.46e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—malaria	5.9e-06	3.46e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—malaria	5.88e-06	3.45e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—KDR—malaria	5.87e-06	3.44e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PKLR—malaria	5.86e-06	3.43e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—malaria	5.8e-06	3.4e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—malaria	5.72e-06	3.36e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—malaria	5.64e-06	3.31e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—malaria	5.6e-06	3.28e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—malaria	5.54e-06	3.25e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—malaria	5.45e-06	3.19e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—G6PD—malaria	5.22e-06	3.06e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—malaria	5.21e-06	3.05e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—malaria	5.21e-06	3.05e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—malaria	5.2e-06	3.05e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—malaria	5.17e-06	3.03e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—malaria	5.17e-06	3.03e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HPGDS—malaria	5.16e-06	3.02e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—malaria	5.15e-06	3.02e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—KDR—malaria	5.14e-06	3.01e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—malaria	5.13e-06	3.01e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—malaria	4.96e-06	2.9e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—malaria	4.95e-06	2.9e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CD36—malaria	4.93e-06	2.89e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—malaria	4.87e-06	2.85e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DHFR—malaria	4.79e-06	2.8e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SCARB1—malaria	4.74e-06	2.78e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CD36—malaria	4.66e-06	2.73e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—malaria	4.61e-06	2.7e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—malaria	4.6e-06	2.7e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—malaria	4.58e-06	2.68e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—malaria	4.58e-06	2.68e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—malaria	4.56e-06	2.67e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—KDR—malaria	4.55e-06	2.67e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—malaria	4.42e-06	2.59e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—malaria	4.19e-06	2.45e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—malaria	4.15e-06	2.43e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—malaria	4.14e-06	2.43e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—malaria	4.08e-06	2.39e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—malaria	4.06e-06	2.38e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—malaria	4e-06	2.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HPGDS—malaria	3.98e-06	2.33e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—malaria	3.87e-06	2.27e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—malaria	3.85e-06	2.26e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—malaria	3.8e-06	2.23e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—malaria	3.79e-06	2.22e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—malaria	3.78e-06	2.22e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—malaria	3.77e-06	2.21e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CD36—malaria	3.72e-06	2.18e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—malaria	3.69e-06	2.16e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DHFR—malaria	3.69e-06	2.16e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—malaria	3.68e-06	2.15e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SCARB1—malaria	3.65e-06	2.14e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—malaria	3.65e-06	2.14e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—malaria	3.64e-06	2.13e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—malaria	3.5e-06	2.05e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—malaria	3.48e-06	2.04e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—malaria	3.46e-06	2.03e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—malaria	3.36e-06	1.97e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—malaria	3.33e-06	1.95e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—malaria	3.2e-06	1.88e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—malaria	3.19e-06	1.87e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—malaria	3.03e-06	1.77e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CD36—malaria	2.97e-06	1.74e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—malaria	2.95e-06	1.73e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—malaria	2.86e-06	1.68e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—malaria	2.8e-06	1.64e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—malaria	2.71e-06	1.59e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—malaria	2.68e-06	1.57e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—malaria	2.47e-06	1.45e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—malaria	2.44e-06	1.43e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—malaria	2.39e-06	1.4e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—malaria	2.35e-06	1.38e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CD36—malaria	2.29e-06	1.34e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—malaria	2.26e-06	1.33e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—malaria	2.23e-06	1.31e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—malaria	1.96e-06	1.15e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—malaria	1.73e-06	1.02e-05	CbGpPWpGaD
